AFM-12

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameAFM-12

Drug Alias NameAFM-12

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-CD19Anti-Low affinity immunoglobulin gamma Fc region receptor III-A

TargetsLow affinity immunoglobulin gamma Fc region receptor III-AB-lymphocyte antigen CD19

Therapy Area/IndicationsLymphoma, Non-Hodgkin

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAffimed

China Registration ClassN/A

Develop Information

Active CompaniesAffimed

Inactive CompaniesN/A

Active IndicationsLymphoma, Non-Hodgkin

Inactive IndicationsN/A

Other Information

ATC CodeN/A